Work

Correction: Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies

Year: 2019

Type: erratum

Source: Leukemia

DOI: 10.1038/s41375-019-0484-y

Authors: Jinqi Huang, Stepanov Alexey, Jian Li, Terri Jones, Geramie Grande, Lacey Douthit, Jun Xie, Danna Chen, Xiaolei Wu, Maschan Michael, Changchun Xiao, Jiangning Zhao, Xuehua Xie, Jia Xie, Xiao Lei Chen, Guo Fu, Gabibov Alexander, Chi-Meng Tzeng

Institutions: Scripps Research Institute, Xiamen University, Russian Academy of Sciences, Institute of Bioorganic Chemistry, Putian University, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Zhongshan Hospital of Xiamen University, Nanjing Tech University

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2944973216

Cites:

Cited by: 2

Related to: 10